Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies von Centore, Richard C., Sandoval, Gabriel J., Soares, Luis Miguel Mendes, Kadoch, Cigall, Chan, Ho Man

Volltext

Spartan/C1orf124, a Reader of PCNA Ubiquitylation and a Regulator of UV-Induced DNA Damage Response von Centore, Richard C., Yazinski, Stephanie A., Tse, Alice, Zou, Lee

Volltext

TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA von Zou, Lee, Flynn, Rachel Litman, Centore, Richard C, O'Sullivan, Roderick J, Rai, Rekha, Tse, Alice, Songyang, Zhou, Chang, Sandy, Karlseder, Jan

Volltext

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma von Conery, Andrew R, Centore, Richard C, Neiss, Adrianne, Keller, Patricia J, Joshi, Shivangi, Spillane, Kerry L, Sandy, Peter, Hatton, Charlie, Pardo, Eneida, Zawadzke, Laura, Bommi-Reddy, Archana, Gascoigne, Karen E, Bryant, Barbara M, Mertz, Jennifer A, Sims, Robert J

Volltext

CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase von Centore, Richard C, Havens, Courtney G, Manning, Amity L, Li, Ju-Mei, Flynn, Rachel Litman, Tse, Alice, Jin, Jianping, Dyson, Nicholas J, Walter, Johannes C, Zou, Lee

Volltext

Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response von Conery, Andrew R, Centore, Richard C, Spillane, Kerry L, Follmer, Nicole E, Bommi-Reddy, Archana, Hatton, Charlie, Bryant, Barbara M, Greninger, Patricia, Amzallag, Arnaud, Benes, Cyril H, Mertz, Jennifer A, Sims, 3rd, Robert J

Volltext

XthA (Exonuclease III) regulates loading of RecA onto DNA substrates in log phase Escherichia coli cells von Centore, Richard C, Lestini, Roxane, Sandler, Steven J

Volltext

UvrD Limits the Number and Intensities of RecA-Green Fluorescent Protein Structures in Escherichia coli K-12 von CENTORE, Richard C, SANDLER, Steven J

Volltext

Differential requirements of two recA mutants for constitutive SOS expression in Escherichia coli K-12 von Long, Jarukit Edward, Renzette, Nicholas, Centore, Richard C, Sandler, Steven J

Volltext

UvrD303, a Hyperhelicase Mutant That Antagonizes RecA-Dependent SOS Expression by a Mechanism That Depends on Its C Terminus von CENTORE, Richard C, LEESON, Michael C, SANDIER, Steven J

Volltext

Localization of RecA in Escherichia coli K‐12 using RecA–GFP von Renzette, Nicholas, Gumlaw, Nathan, Nordman, Jared T., Krieger, Marlee, Yeh, Su‐Ping, Long, Edward, Centore, Richard, Boonsombat, Ruethairat, Sandler, Steven J.

Volltext

Direct Role for Proliferating Cell Nuclear Antigen in Substrate Recognition by the E3 Ubiquitin Ligase CRL4Cdt2 von Havens, Courtney G., Shobnam, Nadia, Guarino, Estrella, Centore, Richard C., Zou, Lee, Kearsey, Stephen E., Walter, Johannes C.

Volltext

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma von Conery, Andrew R, Centore, Richard C, Neiss, Adrianne, Keller, Patricia J, Joshi, Shivangi, Spillane, Kerry L, Sandy, Peter, Hatton, Charlie, Pardo, Eneida, Zawadzke, Laura, Bommi-Reddy, Archana, Gascoigne, Karen E, Bryant, Barbara M, Mertz, Jennifer A, Sims, Robert J

Volltext

Abstract B21: Identifying mechanisms of resistance to BET bromodomain inhibition von Centore, Richard C., Hatton, Charlie, Bryant, Barbara, Sims, Robert J.

Volltext

Abstract 1224: Discovery of novel BAF inhibitors for the treatment of transcription factor-driven cancers von Centore, Richard C., Soares, Luis M., Vaswani, Rishi G., Ichikawa, Kana, Li, Zhifang, Fan, Hong, Setser, Jeremy, Lahr, David L., Zawadzke, Laura, Chen, Xueying, Barnash, Kimberly D., Muwanguzi, Jordana, Anthony, Neville, Sandoval, Gabriel J., Feldman, Katharine, Adam, Ammar, Huang, David, Schiller, Shawn, Wilson, Kevin, Voigt, Johannes, Hentemann, Martin, Millan, David S., Chan, Ho Man, Bellon, Steven F., Decicco, Carl P., Xu, Lan

Volltext

888 Synergistic efficacy of the BRM/BRG1 ATPase inhibitor, FHD-286, and anti-PD-1 antibody in mouse syngeneic tumor models von Ichikawa, Kana, Ammar, Adam, Hsin-Jung, Wu, Lahr, David, Xu, Lan, Antonakos, Brandon, Johannessen, Liv, Bellon, Steven, Kruger, Ryan, Centore, Richard, Hentemann, Martin

Volltext

Abstract A064: Establishing the cellular and molecular impacts of the dual BRM/BRG1 inhibitor FHD-286 on pre-clinical models of non-small cell lung cancer (NSCLC) von Wilson, Molly M., Adam, Ammar, Amaral, Victoria, Mikse, Oliver, Elliott, GiNell, Lahr, David L., Gartin, Ashley K., Wan, Jessica, Johannessen, Liv, Ichikawa, Kana, Feldman, Katharine, Piel, Jessica, Sandoval, Gabriel J., Centore, Richard C., Bellon, Steven F., Hentemann, Martin

Volltext

Abstract A053: The dual BRG1/BRM (SMARCA4/2) inhibitor FHD-286 induces functional differentiation and splicing defects in preclinical models of acute myeloid leukemia (AML) von Gartin, Ashley K., Mayhew, David N., Lahr, David L., Elliott, GiNell, Gandevia, Heena, Wilson, Molly M., Centore, Richard, Collins, Mike, Thomsen, Astrid, Piel, Jessica, Sandoval, Gabriel J., Hentemann, Martin

Volltext

Abstract A056: Treatment with dual BRG1/BRM (SMARCA4/2) inhibitor FHD-286 ablates tumor-associated androgen response elements (AREs) in prostate cancer von Sandoval, Gabriel J, Centore, Richard C, Topal, Sal, Lahr, Dave, Elliott, GiNell, Gandevia, Heena, Adam, Ammar, Piel, Jessica, Nguyen, Holly M, Corey, Eva, Chen, Yu, Bellon, Steven, Hentemann, Murphy

Volltext

Abstract 4749: Bromodomain inhibition of the transcriptional coactivators CBPEP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma von Keller, Patricia J, Conery, Andrew R, Centore, Richard C, Bommi-Reddy, Archana, Gascoigne, Karen E, Bryant, Barbara M, Mertz, Jennifer A, Sims, Robert J

Volltext